Your complete solution for NGS cancer test interpretation and reporting through evidence-based clinical decision support, QCI Interpret,
has been enhanced yet again. Take a look at these highlights of features and benefits in our latest release.
In hereditary cancers, clear insight into genomic risk factors helps navigate better patient care. With QIAGEN Clinical Insight (QCI™) Interpret for Hereditary Cancer you no longer need to go to various sites and sources to score NGS variants. QCI Interpret is a comprehensive clinical decision support solution with manually curated scientific evidence for germline cancers. Having all the information you need aggregated in one place saves time and improves interpretation of NGS variants which ultimately helps increase clinical decision accuracy.
QCI Interpret replaces your complex and manual clinical NGS variant research with a scalable interpretation workflow alternative that helps grow your indication menu and volume. With QCI Interpret for Hereditary Cancer you can:
QCI Interpret is an efficiency tool that helps you identify pathogenic variants fast with results you can trust, all in one secure web application. With QCI Interpret you get:
Find out if QCI interpret for Hereditary Cancer fits your NGS interpretation and reporting needs. Speak to a representative from QIAGEN Bioinformatics to take a closer look at a few representative data sets of variants that have been through a QCI™ Interpret workflow. Explore the easy-to-use interface, familiarize yourself with the various powerful features, see for yourself the detailed bibliography functionality, and practice building a comprehensive report.
Request your free, no obligation, demonstration of QCI™ Interpret for Hereditary Cancer today.
*QCI Interpret is an evidence-based decision support software intended as an aid in the interpretation of variants observed in genomic sequencing data. The software evaluates genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and clinical-trials. Based on this evaluation, the software proposes a classification to aid in the interpretation of observed variants. The software is NOT intended as a primary diagnostic tool by physicians or to be used as a substitute for professional healthcare advice. Each laboratory is responsible for ensuring compliance with applicable international, national, and local clinical laboratory regulations and other specific accreditations requirements.
© QIAGEN 2017. All rights reserved - Trademarks & Disclaimers